Alnylam Pharmaceuticals, Inc. (ALNY): Price and Financial Metrics


Alnylam Pharmaceuticals, Inc. (ALNY)

Today's Latest Price: $91.44 USD

2.28 (2.56%)

Updated Oct 23 11:48am

Add ALNY to Watchlist
Sign Up

Overall POWR Rating


POWR Components:

 Trade Grade  Buy & Hold Grade  Peer Grade  Industry Rank


Industry Rank:

Ranked of 329 in Biotech

See all "A" rated Strong Buy stocks

ALNY Stock Summary

  • Alnylam Pharmaceuticals Inc's capital turnover -- a measure of revenue relative to shareholder's equity -- is better than just 10.22% of US listed stocks.
  • ALNY's price/sales ratio is 89.83; that's higher than the P/S ratio of 97.91% of US stocks.
  • With a year-over-year growth in debt of 1,021.86%, Alnylam Pharmaceuticals Inc's debt growth rate surpasses 97.55% of about US stocks.
  • Stocks that are quantitatively similar to ALNY, based on their financial statements, market capitalization, and price volatility, are RESN, HRTX, BCDA, ATOM, and EDIT.
  • Visit ALNY's SEC page to see the company's official filings. To visit the company's web site, go to www.alnylam.com.
ALNY Daily Price Range
ALNY 52-Week Price Range

ALNY Stock Price Chart More Charts


ALNY Price/Volume Stats

Current price $91.44
Prev. close $89.16
Day low $88.81
Day high $91.49
50-day MA $81.89
200-day MA $79.88
52-week high $96.08
52-week low $60.27
Volume 153,140
Avg. volume 814,422
Dividend yield N/A
Market Cap 10.17B

Alnylam Pharmaceuticals, Inc. (ALNY) Company Bio


Alnylam Pharmaceuticals is a biopharmaceutical company developing novel therapeutics based on RNA interference, or RNAi. The company was founded in 2002 and is based in Cambridge, Massachusetts.





ALNY Latest News Stream


Event/Time News Detail
Loading, please wait...

ALNY Latest Social Stream


Loading social stream, please wait...

View Full ALNY Social Stream

ALNY Price Returns

1-mo 7.91%
3-mo 23.33%
6-mo 5.03%
1-year 19.37%
3-year 149.36%
5-year -2.56%
YTD 25.41%
2018 -42.61%
2017 239.34%
2016 -60.23%
2015 -2.95%
2014 50.86%

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!



Page generated in 0.6257 seconds.